Allbiotech introduces cost-effective Genesys V1 bioreactor for precision fermentation research

Allbiotech, a Spain-based manufacturer of laboratory equipment for precision fermentation research, has completed the first production run of its Genesys V1 bioreactor. Designed to support early-stage development and process optimization, Genesys V1 provides a cost-effective alternative for food tech startups, research institutions, and companies looking to advance fermentation-based innovation without the high costs associated with pharmaceutical-grade systems.

With a price point approximately one-third that of traditional bioreactors, Genesys V1 is intended to improve accessibility for researchers and startups working in food technology. The system has been developed to simplify experimentation while maintaining the features necessary for reliable data collection. Following validation of the initial units, Allbiotech has introduced refinements to enhance both usability and performance. The compact one-liter system includes a remote-control interface, automated cycle management, and real-time monitoring, making it a practical tool for precision fermentation research.

Genesys V1 consists of a control unit equipped with a touchscreen interface, integrated electronic components, and peristaltic pumps. The reactor unit includes a glass vessel with a stainless steel lid, sensors, and a stainless steel Rushton agitator designed to ensure uniform mixing and shear force generation. The system supports precise control of fermentation conditions through five peristaltic pumps, allowing for regulated liquid addition and environmental adjustments such as oxygen levels, pH, and temperature. An integrated air oxygenation pump removes the need for external equipment, while the system’s automated agitation and aeration mechanisms enable precise oxygen management.

Additional features include an automated cycle control function, real-time data logging, and a software platform for visualization and monitoring. A configurable cascade PID system ensures accurate oxygenation, while manual controls provide flexibility for direct adjustments. The design prioritizes ease of use with tool-free sensor mounting, vessel opening, and agitator setup, allowing researchers to focus on experimentation rather than equipment handling. Constructed from stainless steel and glass, the system is built for durability and easy maintenance.

Pablo Goñi, Founder of Allbiotech, explains that the goal of Genesys V1 is to make precision fermentation research more accessible. "A key objective of Genesys V1 was to remove financial barriers to entry for researchers and companies exploring precision fermentation. By leveraging our experience in high-tech equipment manufacturing, we have created a functional, cost-effective bioreactor that allows more innovators to engage in fermentation research without requiring large investments."

In January, Allbiotech secured funding to expand its production and commercialization efforts. The investment round was led by Daniel Palacio of Tutti Food Group and included backing from multiple investors, including former professional athlete and engineer Ibai Meoki, innovation specialist Ignacio Hernández, and several professionals from the agri-food sector. The capital will support an upcoming production run in March, with early orders receiving special conditions.

Daniel Palacio sees Genesys V1 as a valuable tool for advancing sustainable food production. "Supporting innovative projects in precision fermentation is key to developing new food ingredients and improving sustainability. Genesys V1 provides an accessible and practical tool for researchers and startups working in this space."

Allbiotech was founded in June 2024 by Pablo Goñi with a focus on developing and manufacturing fermentation equipment tailored to the food tech sector. Many startups in this field rely on costly pharmaceutical laboratory tools that are not designed for agri-food applications. By offering a more affordable alternative, Allbiotech aims to enable greater innovation in precision fermentation.

Goñi is also the founder and CEO of Noxon, a company producing audiovisual equipment using resource-efficient materials. Allbiotech plans to follow a similar international sales model, bypassing traditional distributors and leveraging digital platforms to reach food tech innovators worldwide.